Nasdaq Cnsp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq cnsp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cnsp Today - Breaking & Trending Today

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Up 30.6% in December

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 54,200 shares, an increase of 30.6% from the November 30th total of 41,500 shares. Currently, 0.9% of the shares of the company are short sold. Based […] ....

Pharmaceuticals Stock Performance , Pharmaceuticals Inc , Cns Pharmaceuticals Inc , Renaissance Technologies , Pharmaceuticals Daily , York Mellon Corp , Virtu Financial , Armistice Capital , Pharmaceuticals Company Profile , Get Free Report , New York Mellon Corp , State Street Corp , Cns Pharmaceuticals , Nasdaq Cnsp ,

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Down 45.2% in September

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 67,000 shares, a decline of 45.2% from the August 31st total of 122,300 shares. Currently, 1.6% of the company’s stock are sold short. […] ....

Christopher Downs , Pharmaceuticals Daily , Pharmaceuticals Price Performance , Wealth Advisors , Pharmaceuticals Inc , Acadian Asset Management , Renaissance Technologies , Geode Capital Management , Cns Pharmaceuticals Inc , Virtu Financial , Get Free Report , Capital Management , Cns Pharmaceuticals , Nasdaq Cnsp ,

Short Interest in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Expands By 91.6%

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 229,100 shares, a growth of 91.6% from the May 15th total of 119,600 shares. Based on an average daily trading volume, of 3,560,000 shares, the days-to-cover ratio […] ....

Armistice Capital , Pharmaceuticals Daily , Cns Pharmaceuticals Inc , York Mellon Corp , Pharmaceuticals Stock Performance , Pharmaceuticals Inc , Virtu Financial , Renaissance Technologies , Get Rating , New York Mellon Corp , Cns Pharmaceuticals , Nasdaq Cnsp ,

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Sees Large Increase in Short Interest

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 229,100 shares, a growth of 91.6% from the May 15th total of 119,600 shares. Approximately 5.7% of the company’s stock are short sold. Based […] ....

Cns Pharmaceuticals Inc , Renaissance Technologies , Virtu Financial , Pharmaceuticals Trading , Pharmaceuticals Inc , Armistice Capital , York Mellon Corp , Pharmaceuticals Company Profile , Pharmaceuticals Daily , Get Rating , New York Mellon Corp , Cns Pharmaceuticals , Nasdaq Cnsp ,

Short Interest in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Increases By 306.4%

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) saw a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 215,800 shares, an increase of 306.4% from the April 15th total of 53,100 shares. Based on an average daily volume of 3,210,000 shares, the days-to-cover ratio is […] ....

Virtu Financial , Pharmaceuticals Company Profile , Pharmaceuticals Daily , Renaissance Technologies , Pharmaceuticals Stock Performance , Armistice Capital , York Mellon Corp , Cns Pharmaceuticals Inc , Pharmaceuticals Inc , Get Rating , New York Mellon Corp , Cns Pharmaceuticals , Nasdaq Cnsp ,